Subject Index Volume 108 (2005)

Journal of Controlled Release 108 (2005) 574 – 576 www.elsevier.com/locate/jconrel

Subject Index Volume 108 (2005) A549, (108) 244 AAV, (108) 161 Alzheimer’s disease, (108) 193 Amorphous, (108) 306 Amphiphilic, (108) 226 Antibiotics, (108) 341 Antibody, (108) 418 Anticancer activity, (108) 244 Anticancer agents, (108) 215 Apoptosis, (108) 121, (108) 442 Apparent degree of neutralization, (108) 150 Asialoglycoprotein receptor, (108) 557 Atopic dermatitis, (108) 294 ATP, (108) 460 Barton’s esters, (108) 215 Bilayered tablet, (108) 351 Bioadhesion, (108) 10 Bioavailability, (108) 351 Biocompatibility, (108) 43 Biocompatible, (108) 263 Biodegradability, (108) 43 Biodegradation, (108) 226 Block copolymer, (108) 496 Blood–brain barrier, (108) 84, (108) 193 Caco-2, (108) 56 Cancer, (108) 418 Cationic, (108) 418 Cationic liposomes, (108) 484 Cationization, (108) 540 CCL-186, (108) 244 Cell penetrating peptide, (108) 396 Cell viability, (108) 472 Central nervous system, (108) 193 Claudin-4, (108) 56 Clostridium perfringens enterotoxin, (108) 56 Cloxacillin sodium, (108) 150 a-Cobrotoxin, (108) 10 Collagen, (108) 178 Computational modelling, (108) 132 Confocal microscopy, (108) 472

doi:10.1016/S0168-3659(05)00557-2

Contrast agent, (108) 21 Controlled release, (108) 132, (108) 237 Controlled release systems, (108) 263 Core-shell, (108) 237 Core–shell, (108) 97 CpG-ODN, (108) 294 CPT-11, (108) 453 Cultured human skin, (108) 341 h-cyclodextrin, (108) 215 Cytomegalovirus retinitis, (108) 282 Cytotoxicity, (108) 63, (108) 442 d-(Arg)-kyotorphin, (108) 319 Degradation, (108) 1 Dermal patch, (108) 341 Dextran, (108) 97 Diffusion model, (108) 341 Dioleoylphosphatidylglycerol, (108) 442 Disintegration, (108) 386 DNA localization, (108) 513 DOPE, (108) 484 Dose dumping, (108) 375 Doxorubicin, (108) 140 Drug delivery, (108) 33, (108) 396, (108) 409, (108) 433 Drug eluting stent, (108) 178 Drug release, (108) 306, (108) 362 Drug release equations, (108) 282 Drug-loaded LSE-high, (108) 341 Dual release, (108) 351 Dynamic light scattering, (108) 150 Echocardiography, (108) 21 Elastin-like polypeptide, (108) 396 Electromigration, (108) 319 Electroosmosis, (108) 319 Electrospinning, (108) 33, (108) 237 Emulsion, (108) 33, (108) 418 Encapsulation, (108) 226 Enhanced gene expression, (108) 540 Enzymatic degradation, (108) 263 EPR, (108) 215 Extended release, (108) 375

Subject Index Volume 108 (2005) Felodipine, (108) 375 Ferritin, (108) 418 Film loading method, (108) 453 folate, (108) 121 Food interactions, (108) 375 Formulation optimization, (108) 331 Ganciclovir, (108) 282 Gels, (108) 73 Gene delivery, (108) 472, (108) 484, (108) 513, (108) 529 Gene expression, (108) 496 Gene therapy, (108) 161 Genipin, (108) 178 Glass transition temperature, (108) 1 H1299, (108) 244 Haemolysis, (108) 63 Hepatocellular carcinoma animal model, (108) 557 Herbicide, (108) 132 Humans, (108) 43 Hydrogel, (108) 331 In situ-forming implant, (108) 433 Inflammation, (108) 496 Interfacial tension, (108) 73 Intracellular drug delivery, (108) 140 Iontophoresis, (108) 319 Ischemia, (108) 460 Isolated rat heart, (108) 460 Isopropyl myristate (IPM), (108) 244 Ketotifen, (108) 306 l-alanine organogelators, (108) 433 Leuprolide, (108) 433 Liposome, (108) 453 Liposomes, (108) 460 Liver, (108) 161 Lung cancer, (108) 244 Macrophages, (108) 442 Magnetic marker monitoring, (108) 375 Mannose receptor, (108) 484 Mannosylated liposomes, (108) 484 Mechanical functions, (108) 460 Membrane, (108) 112 Membrane contactor, (108) 112 Membrane reactor, (108) 112 Membrane transduction, (108) 409 Microparticle, (108) 21 Microparticles, (108) 362 Microsphere, (108) 10 Microspheres, (108) 271, (108) 282 Minimum-sized gene transfer vector, (108) 529 Molecular imprinting, (108) 132 Monolithic HPMC matrix tablet, (108) 351

575

MTT assay, (108) 472 Multivariate spline interpolation, (108) 331 Naltrexone-poly(dl-lactide) implant, (108) 43 Nanoparticle, (108) 97 Nanoparticles, (108) 84, (108) 112, (108) 193, (108) 226 Nasal delivery, (108) 10 NFnB, (108) 496 Nilvadipine, (108) 386 Optimization, (108) 513 Organogel, (108) 433 Oxidation, (108) 442 p16, (108) 409 p53, (108) 496 Paclitaxel, (108) 244 PEG introduction, (108) 540 PEGylation, (108) 63, (108) 161 PEI, (108) 121 Penetratin, (108) 396 Penetration enhancement, (108) 306 Peptides, (108) 84, (108) 319 Percolation theory, (108) 271 PFG NMR, (108) 271 Photopolymerization, (108) 331 pH-responsive, (108) 63 pH-responsive micelles, (108) 140 PLA-F127-PLA nanoparticles, (108) 263 Plasmid DNA, (108) 496 Plasticization, (108) 1 PLGA, (108) 1, (108) 84 PLGA nanoparticle, (108) 244 Poly(2-ethyl-2-oxazoline), (108) 140 Polyacrylic acid modified with 2-hydroxyethyl methacrylate, (108) 331 Polyanhydride, (108) 10 Poly(q-caprolactone), (108) 97 Polyethylenimine, (108) 557 Poly(g-glutamic acid), (108) 226 Polylactide, (108) 33 Poly(l-lactide), (108) 140 Polysaccharide/DNA complex, (108) 529 Poly(styrene-b-2-vinyl pyridine-b-ethylene oxide), (108) 150 Porous silicon, (108) 362 Pressure sensitive adhesive, (108) 306 Rabbit myocardial infarction, (108) 460 Readministration, (108) 161 Receptor-mediated endocytosis, (108) 121 Release kinetics, (108) 271 Reperfusion, (108) 460 Rev-caspase-3, (108) 121 Schizophyllan, (108) 529 Shear-induced release, (108) 73

576

Subject Index Volume 108 (2005)

Simazine, (108) 132 Sirolimus, (108) 178 Skeletal muscle, (108) 496 Skin permeation, (108) 306 SN-38, (108) 453 Solid dispersion, (108) 386 Solid lipid nanoparticles, (108) 112 Solvent casting method, (108) 306 Spin trapping, (108) 215 Spray dry, (108) 21 Supersaturation, (108) 306 Surface, (108) 97 Sustained release, (108) 43, (108) 386 Swelling mechanism, (108) 351

Thermally carbonized silicon, (108) 362 Thermally oxidized silicon, (108) 362 Thermogelling polymers, (108) 282 Thermoresponsive polymers, (108) 472 Tight junction, (108) 56 Transcription, (108) 496 Transdermal administration, (108) 294 Transepithelial electric resistance, (108) 56 Transfection efficiency, (108) 513 Transgene expression, (108) 472 Tumor targeting, (108) 540

Tape-stripping, (108) 319 Targeted drug delivery, (108) 193 Targeting, (108) 84 Tat, (108) 396 Technetium-99m, (108) 557 Th1/Th2 balance, (108) 294 Therapeutic ultrasound, (108) 513

Vesicles, (108) 263

Ultrasound, (108) 21 Ultrasound irradiation, (108) 540

Water, (108) 1 Wax, (108) 386 Wheat germ agglutinin (WGA), (108) 244 Zeta-potential, (108) 150